| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/24/2011 | CA2441235C Aryl and biaryl compounds having mch modulatory activity |
| 05/24/2011 | CA2421562C A method of producing analgesia using sodium channel blocking compounds such as tetrodotoxin, saxitoxin and derivatives thereof |
| 05/24/2011 | CA2412947C Method for treating a movement disorder |
| 05/24/2011 | CA2401604C Method of treating cancer with anti-neurotrophin agents |
| 05/24/2011 | CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby |
| 05/24/2011 | CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 05/24/2011 | CA2345201C Mature protein having antagonistic activity against bone morphogenetic protein |
| 05/24/2011 | CA2344816C Medicinal aerosol formulation |
| 05/24/2011 | CA2342064C Long wave length absorbing bacteriochlorin alkyl ether analogs |
| 05/24/2011 | CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors |
| 05/24/2011 | CA2229631C Gene therapy using ovine adenoviral vectors |
| 05/24/2011 | CA2211687C Vascular endothelial growth factor-b |
| 05/19/2011 | WO2011059085A1 Prophylactic or therapeutic agent for dyslipidemia-related arteriosclerosis |
| 05/19/2011 | WO2011059080A1 Isotope-substituted diamine derivative |
| 05/19/2011 | WO2011059053A1 Therapeutic or prophylactic agent for diabetes |
| 05/19/2011 | WO2011059042A1 Aromatic ring compound |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058993A1 Method for screening for novel bone resorption inhibitor |
| 05/19/2011 | WO2011058982A1 Therapeutic agent for gastrointestinal diseases |
| 05/19/2011 | WO2011058933A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing same |
| 05/19/2011 | WO2011058923A1 Antibacterial agent for drug-resistant bacteria, method for screening for same, and use of same |
| 05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
| 05/19/2011 | WO2011058763A1 Aminothiazine or aminooxazine derivative having amino linker |
| 05/19/2011 | WO2011058366A1 Use of bethanechol for treatment of xerostomia |
| 05/19/2011 | WO2011057471A1 Methods and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor |
| 05/19/2011 | WO2010151020A3 Fast-dissolving oral film for effectively concealing unpleasant tastes |
| 05/19/2011 | WO2010057856A8 Use of escin for treatment of type iv hypersensitivity reaction |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118359 Ampk activating agent |
| 05/19/2011 | US20110118344 Novel compound having inhibitory effect on lipase |
| 05/19/2011 | US20110118305 Compounds |
| 05/19/2011 | US20110118226 Transdermal pharmaceutical compositions comprising danazol |
| 05/19/2011 | US20110118223 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/19/2011 | US20110117217 Method of using guava extract |
| 05/19/2011 | US20110117212 Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agent |
| 05/19/2011 | US20110117211 Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of Mucosa |
| 05/19/2011 | US20110117206 Phosphopeptides and use of the same |
| 05/19/2011 | US20110117168 Methods and compositions for soft tissue repair |
| 05/19/2011 | US20110117163 Bioactive coating for an implantable device or bioprosthesis |
| 05/19/2011 | US20110117148 Whitened exine shells |
| 05/19/2011 | US20110117136 Dehydroepiandrosterone production promoter and use thereof |
| 05/19/2011 | US20110117108 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 05/19/2011 | US20110117105 Method of treating immune disease using b-cell antibodies |
| 05/19/2011 | US20110117067 Glucanases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 05/19/2011 | US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 05/19/2011 | US20110117027 Injectable void filler for soft tissue augmentation |
| 05/19/2011 | US20110117014 Non-invasive diagnostic agents and methods of diagnosing infectious disease |
| 05/19/2011 | US20110117012 Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr expression in malignant tumors |
| 05/19/2011 | US20110117010 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
| 05/19/2011 | US20110117008 Use of avicins to deliver therapeutic and diagnostic agents |
| 05/19/2011 | CA2780683A1 Therapeutic or prophylactic agent for diabetes |
| 05/19/2011 | CA2780256A1 Use of bethanechol for treatment of xerostomia |
| 05/19/2011 | CA2779508A1 Method and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor |
| 05/19/2011 | CA2779417A1 Therapeutic agent for gastrointestinal disease |
| 05/19/2011 | CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/18/2011 | EP2322933A1 Diagnosis of carcinomas |
| 05/18/2011 | EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy |
| 05/18/2011 | EP2322608A1 Transfection agent |
| 05/18/2011 | EP2322601A1 Method of collecting placental stem cells |
| 05/18/2011 | EP2322545A1 Analogues of GLP-1 |
| 05/18/2011 | EP2322501A1 4-dedimethylamino tetracycline compounds |
| 05/18/2011 | EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 05/18/2011 | EP2322226A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 05/18/2011 | EP2322224A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 05/18/2011 | EP2322218A1 Methods of modulating CD200 receptors |
| 05/18/2011 | EP2322210A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 05/18/2011 | EP2322199A1 Growth differentiation factor receptors, and methods of using same |
| 05/18/2011 | EP2322193A1 Xanthine oxidase inhibitor and uric acid production inhibitor |
| 05/18/2011 | EP2322179A1 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders |
| 05/18/2011 | EP2322174A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes |
| 05/18/2011 | EP2322169A1 Composition containing a DHA oil for use in the treatment of cystic fibrosis |
| 05/18/2011 | EP2322165A1 Apo2 ligand/TRAIL formulations |
| 05/18/2011 | EP2322164A2 Carbonylamino derivatives useful for the treatment of inflammatory bowel disease |
| 05/18/2011 | EP2322160A1 Methods of inducing terminal differentiation |
| 05/18/2011 | EP2320954A1 Diagnostic agents selective against metalloproteases |
| 05/18/2011 | EP2320879A2 Pharmaceutical composition comprising jasmonates |
| 05/18/2011 | EP1662007B1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/18/2011 | EP1192136B1 Oligomers and polymers of cyclic imino carboxylic acids |
| 05/18/2011 | CN1527704B Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 05/18/2011 | CN102066930A Method of bioassaying yokkansan |
| 05/18/2011 | CN102066337A 5-hydroxypyrimidine-4-carboxamide compound |
| 05/18/2011 | CN102066328A Iminopyridine derivative and use thereof |
| 05/18/2011 | CN102066326A Pyridone compound |
| 05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
| 05/18/2011 | CN102065856A Combination of dronedarone with at least one diuretic, and therapeutic use thereof |
| 05/18/2011 | CN102060911A Polypeptide combined with various amyloid protein monomers simultaneously and application thereof |
| 05/18/2011 | CN102060857A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/18/2011 | CN102060842A 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/18/2011 | CN102060809A Rhein derivatives and preparation and application thereof |
| 05/18/2011 | CN102060806A Cytokine inhibitors |
| 05/18/2011 | CN102058663A Clathrate compound formed by Salvia miltiorrhiza Bunge and cyclodextrin and application thereof |
| 05/18/2011 | CN102058625A High-efficient anti-stress agent for aquaculture |
| 05/18/2011 | CN102058614A Use of adenosine receptor agonists in therapy |
| 05/18/2011 | CN102058597A Use of flibanserin in the treatment of sexual disorders |
| 05/18/2011 | CN102058570A Application of carnosic acid in preparing medicament for suppressing angiogenesis |
| 05/18/2011 | CN102058547A Freeze-dried preparation |
| 05/18/2011 | CN102058500A Health-care bath agent for improving microcirculation |
| 05/18/2011 | CN101632669B Method of using diketopiperazines and composition containing them |
| 05/18/2011 | CN101404996B Composition containing lignan compound |
| 05/18/2011 | CN101352435B Use of lipoamide for preventing and treating age related macular degeneration |